They work by helping your body control blood sugar and by promoting a feeling of fullness, which can reduce appetite and support weight loss
Davidson paid particular attention to calories, carbohydrates, sugars, and electrolytes, with the largest focus on sodium and potassium
Patients with type 2 diabetes carry elevated AF risk, and GLP-1 receptor agonists provide meaningful cardiometabolic benefits
BMI requirements apply regardless of dietary approach
with type 2 diabetes: 62.7% responders and 37.3% non-responders) ( However, the development of newer drugs like tirzepatide offer hope for improved outcomes ( To explore the role of genetic predictors, recent research pooled data from seven major lifestyle intervention trials (NUGENOB, DIOGenes, Look AHEAD, Diabetes Prevention Program, Diabetes Prevention Study, DIETFITS, PREDIMED-PLUS)
Additionally, GLP-1 drugs have been shown to lower the risk of major cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes, regardless of their impact on blood sugar levels
